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Structural Basis of Caspase-7 Inhibition by XIAP
nik, 1998). Once activated, the effector caspases areJijie Chai,* Eric Shiozaki,* Srinivasa M.
Srinivasula,† Qi Wu,* Pinaki Dataa,† responsible for the proteolytic degradation of a broad
spectrum of cellular targets that ultimately lead to cellEmad S. Alnemri,† and Yigong Shi*‡
*Department of Molecular Biology death. Among the effector caspases, caspase-3 shares
54 percent sequence identity with caspase-7 (Fernan-Princeton University
Lewis Thomas Laboratory des-Alnemri et al., 1995); these two caspases exhibit
highly similar structures and function.Washington Road
Princeton, New Jersey 08544 The inhibitor of apoptosis (IAP) family of proteins sup-
press programmed cell death by physically interacting†Kimmel Cancer Center
233 S. 10th Street with and inhibiting the catalytic activity of caspases (De-
veraux and Reed, 1999; Miller, 1999). At least sevenThomas Jefferson University
Philadelphia, Pennsylvania 19107 members of the mammalian IAPs have been identified,
including X-linked IAP (XIAP), c-IAP1, c-IAP2, and sur-
vivin (Deveraux and Reed, 1999). The functional building
block in each IAP protein is the so-called baculoviral
IAP repeat (BIR), which contains z80 amino acids foldedSummary
around a zinc atom. Each IAP protein contains at least
one BIR domain and many, including XIAP, containThe inhibitor of apoptosis (IAP) proteins suppress cell
three. The different BIR domains and fragments in thedeath by inhibiting the catalytic activity of caspases.
same IAP protein appear to exhibit distinct functionsHere we present the crystal structure of caspase-7 in
(Deveraux et al., 1999). For example, in XIAP, the thirdcomplex with a potent inhibitory fragment from XIAP
BIR domain (BIR3) potently inhibits the activity of theat 2.45 A˚ resolution. An 18-residue XIAP peptide binds
processed caspase-9 whereas the linker region betweenthe catalytic groove of caspase-7, making extensive
BIR1 and BIR2 selectively targets the active caspase-3contacts to the residues that are essential for its cata-
(Takahashi et al., 1998; Sun et al., 1999, 2000; Chai etlytic activity. Strikingly, despite a reversal of relative
al., 2000; Srinivasula et al., 2000). The inhibition is highlyorientation, a subset of interactions between cas-
specific as there is no cross reactivity between thesepase-7 and XIAP closely resemble those between cas-
two fragments of XIAP. The molecular mechanisms ofpase-7 and its tetrapeptide inhibitor DEVD-CHO. Our
caspase inhibition by IAPs are unclear.biochemical and structural analyses reveal that the
In apoptotic cells, the caspase inhibition by IAPs isBIR domains are dispensable for the inhibition of cas-
negatively regulated by a mitochondrial protein Smac/pase-3 and -7. This study provides a structural basis
DIABLO, which is released from the mitochondrial inter-for the design of the next-generation caspase inhib-
membrane space into the cytosol upon apoptotic stimuliitors.
(Du et al., 2000; Verhagen et al., 2000). Smac/DIABLO
physically interacts with multiple IAPs and relieves theirIntroduction
inhibitory effect on both initiator and effector caspases
(Chai et al., 2000; Srinivasula et al., 2000). The removalApoptosis, the prevalent form of programmed cell death,
of caspase-9 inhibition by XIAP appears to involve com-plays a central role in the development and homeostasis
petitive binding to the same surface patch on XIAP-BIR3of all multicellular organisms (Steller, 1995; Jacobson
by caspase-9 and Smac/DIABLO (Liu et al., 2000; Wuet al., 1997; Horvitz, 1999). Alterations in apoptotic path-
et al., 2000; Srinivasula et al., 2001). How Smac/DIABLOways have been implicated in many types of diseases
removes the inhibition of caspase-3 by XIAP is currentlyin human, including cancer, autoimmune diseases, de-
unknown.velopmental, and possibly neurodegenerative disorders
Because the inhibition of caspase activity could prove(Green and Martin, 1995; Thompson, 1995). The mecha-
important for the therapeutic intervention of many dis-nism of apoptosis is remarkably conserved across spe-
eases, structural characterization of caspases has re-cies, executed with a cascade of sequential activation
ceived abundant attention. Structural information is nowof initiator and effector caspases (Chinnaiyan and Dixit,
available on caspase-1 (Walker et al., 1994; Wilson et1996; Thornberry and Lazebnik, 1998; Budihardjo et al.,
al., 1994), caspase-3 (Rotonda et al., 1996; Mittl et al.,1999).
1997), caspase-7 (Wei et al., 2000), and caspase-8Caspases are a family of cysteine proteases that
(Blanchard et al., 1999; Watt et al., 1999). Indeed, pep-cleave their substrates after an aspartate residue. All
tide-based inhibitors of caspases have shown efficacycaspases are produced in cells as catalytically inactive
in animal models of several clinical disorders, includingzymogens. The activation of an effector caspase, such
stroke (Cheng et al., 1998; Endres et al., 1998), traumaticas caspase-3, is performed by an initiator caspase, such
brain injury (Yakovlev et al., 1997), and fulminant liveras caspase-9, through proteolytic cleavage at specific
destruction (Rodriguez et al., 1996). To improve the de-internal Asp residues to separate the large and small
sign and efficacy of new drugs, it is important to examinesubunits of the mature caspase (Thornberry and Lazeb-
the inhibitory mechanisms of caspases by IAPs. How-
ever, despite intense effort, structural information on‡To whom correspondence should be addressed (e-mail: yshi@
molbio.princeton.edu). caspase inhibitors has to date been restricted to cova-
Cell
770
Figure 1. Overall Structure of the Complex between Caspase-7 and an XIAP Fragment
The complex is viewed from three perpendicular angles to exhibit general features of this association (panels A, B, and C). The two heterodimers
of caspase-7 are shown in green and orange, respectively. The bound XIAP fragments are highlighted in pink and blue, respectively. The
catalytic residue Cys186 is colored in yellow. Some of the secondary structural elements are labeled. In panel (D), the experimental electron
density map, shown at 2.5 s, was calculated using phases generated from the molecular replacement solution of caspase-7 after only positional
refinement. The final refined model of the XIAP fragment is also included as a yellow coil. Figures 1, 2, and 3 were prepared using MOLSCRIPT
(Klaulis, 1991).
lently bound tetrapeptides. In particular, there is no pase-7 is opposite to that of the tetrapeptide inhibitor.
In addition, we demonstrate that the BIR domains arestructural information on any caspase bound to a natural
inhibitor. dispensable for caspase-7 inhibition as their primary
role is to maintain a productive conformation for theTo reveal the mechanisms of effector caspase inhibi-
tion by IAPs and to provide a basis for improved drug linker peptide. Furthermore, we suggest a mechanism
for the removal of IAP inhibition to effector caspases bydesign, we have determined the crystal structure of an
active caspase-7 bound to a potent inhibitory domain Smac/DIABLO. These results provide not only a struc-
tural mechanism for effector caspase inhibition but alsofrom XIAP (residues 124–240). The amino-terminal frag-
ment of this XIAP domain fits tightly in the catalytic a useful framework for drug design.
groove on the surface of caspase-7, making numerous
hydrogen bonds and van der Waals contacts to sur- Results
rounding residues. Comparing the binding mode to that
of the tetrapeptide-bound caspases reveals a con- Rationale and Structure Determination
The intervening linker region between the BIR1 and BIR2served pattern of interactions. However, the relative ori-
entation of the XIAP fragment with respective to cas- domains of XIAP was recently shown to be critically
Structure of Caspase-7 Bound to XIAP
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Table 1. Data Collection and Statistics from the Crystallographic Analysis
Data Set Native 1 (RAXIS IV) Native 2 (CHESS-A1)
Resolution (A˚) 99.0–2.7 99.0–2.45
Total observations 93,044 114,661
Unique observations 24,392 30,767
Data coverage (outer shell) 98.1% (95.6%) 96.1% (98.0%)
Rsym (outer shell) 0.061 (0.626) 0.069 (0.458)
Refinement
Resolution range (A˚) 20.0–2.7 20–2.45
Number of reflections (I . s) 21,426 27,625
Rworking/Rfree 22.8%/25.2% 23.6%/27.2%
Number of atoms 3997 3997
Number of waters 19 111
Rmsd bond length (A˚) 0.007 0.007
Rmsd bond angles (degree) 1.395 1.328
Rmsd B factors 2.675 2.687
Rsym 5 ShSijIh,i 2 Ihj/ShSiIh,i, where Ih is the mean intensity of the i observations of symmetry-related reflections of h. R 5 SjFobs 2 Fcalc j/SFobs,
where Fobs 5 FP, and Fcalc is the calculated protein structure factor from the atomic model (Rfree was calculated with 5% of the reflections).
Rmsd in bond lengths and angles are the deviations from ideal values, and the rmsd deviation in B factors is calculated between bonded
atoms.
important for the inhibition of caspase-3 (Sun et al., Each heterodimer of caspase-7 contains a central
6-stranded b sheet (Figure 1A). The b sheet is sur-1999). Interestingly, although mutation of several critical
residues in the linker region abolished caspase-3 inhibi- rounded by two a helices (a2 and a3) and three short
b strands on one side and by three a helices (a1, a4,tion, the linker peptide by itself showed no inhibition,
suggesting additional role by the BIR domains (Sun et and a5) and a b hairpin on the other side. The two
heterodimers of caspase-7 interact through a large hy-al., 1999). Indeed, a fragment of XIAP (residues 124–240),
comprising the complete linker peptide and the BIR2 drophobic surface, adopting a compact globular shape.
The two central b sheets from both subunits associatedomain, was found to potently inhibit caspase-3 (Sun
et al., 1999). This domain interacts strongly with both to form a single twisted 12-stranded b sheet, resulting
in an apparent single folding unit (Figure 1C).active caspase-3 and active caspase-7 and inhibits their
catalytic activities (data not shown). We purified this Four prominent surface loops in each heterodimer
connect the secondary structural elements and protrudeXIAP fragment and the active caspase-7 or caspase-3
to homogeneity separately and reconstituted binary from the structural core, forming the substrate binding
cleft (Figure 1). The catalytic residue Cys186, locatedcomplexes.
Although crystals of complexes involving both cas- on loop L2, is at the bottom of this cleft (Figure 1).
Other residues important for the enzymatic activity ofpases were obtained, only those with caspase-7 exhib-
ited reasonable diffraction quality. Crystals were grown caspase-7 line the inner surface of this cleft.
The bound XIAP fragment starts with a short a helixat room temperature and are in the spacegroup P3221.
The caspase-7 structure was located by molecular re- followed by an extended segment (Figure 1). The XIAP
linker peptide interacts with the catalytic groove andplacement using atomic coordinates of caspase-3 as
the initial search model (PDB code 1CP3). The electron fills the substrate binding pocket. There are 10 intermo-
lecular hydrogen bonds and numerous van der Waalsdensity for the bound XIAP fragment became immedi-
ately apparent after preliminary refinement (Figure 1D). contacts between the XIAP fragment and surrounding
loops in caspase-7, involving both main chain and sideThe final atomic model has been refined to a crystallo-
graphic R factor of 23.6% (Rfree 27.2%) at 2.45 A˚ resolu- chain atoms.
The tertiary and quaternary structure of caspase-7tion, with excellent stereochemical parameters (Table 1).
closely resembles that of other caspases (Thornberry
and Lazebnik, 1998; Wei et al., 2000). For example, theOverall Structure of the Complex
complete Ca backbone atoms of caspase-7 can be su-Although the XIAP fragment in the crystals contains both
perimposed with those of caspase-3 (PDB code 1CP3)the linker region and the BIR2 domain as judged by
with a root-mean-square deviation (RMSD) of 0.7 A˚ (Fig-SDS-PAGE and mass spectroscopic analysis, only an
ure 2). The only visible structural variation is restricted18-residue peptide (134–151) in the linker displayed in-
to the surface loop region, with loops L1 and L4 furtherterpretable electron density. In the crystals, there is a
apart in caspase-7 (Figure 2). The caspase-7-boundlarge solvent cavity immediately next to the carboxyl
XIAP fragment overlaps with the covalently bound tetra-terminus of this XIAP fragment, which is much larger
peptide inhibitor to caspase-3 (Figure 2).than what is needed to accommodate the disordered
BIR2 domain. As will be discussed in detail, this small
fragment fully accounts for XIAP inhibition to effector Interface between XIAP and Caspase-7
The substrate binding pocket on caspase-7 is formedcaspases. The final refined model of the complex con-
tains a complete catalytic unit of caspase-7 comprising by four surface loops, L1, L2, L3, and L4 (Figures 3 and
4). The catalytic dyad residues, Cys186 and His144, aretwo p20-p10 heterodimers and two tightly-bound XIAP
fragments (Figure 1). positioned at the bottom of this pocket. Binding of the
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of Gly144 in XIAP is in close contact with the catalytic
dyad residues Cys186 and His144.
The other binding region involves predominantly hy-
drogen bonds, with residues from the C-terminal half of
the extended XIAP segment networking with caspase-7
residues on loops L3 and L4 (Figure 3D and 4). At the
center of this network, the carboxylate side chain of
Asp148 on XIAP accepts two intermolecular hydrogen
bonds, one from the Ne1 atom of Trp240 and the other
from the backbone amide nitrogen of Gln276 (Figure
3D). In addition, the amide groups of Asp148 and Ile149
each donates one hydrogen bond to the carbonyl oxy-
gen of Arg233 and Gln276, respectively (Figure 3D). The
anchoring interactions involving Asp148 are buttressed
by additional hydrogen bonds between Ser150 of XIAP
and Arg237 and Gln276 of caspase-7 (Figure 3D).
Mechanisms of Caspase-7 Inhibition by XIAP
Previous work has identified several residues in XIAP
that are important for the inhibition of caspase-3 activity.
In particular, mutation of Asp148 or Leu141 to Ala nearly
abolished the inhibition, while mutations of several other
residues, including Val147 and Ile149, decreased inhibi-
tion significantly (Sun et al., 1999). Our crystal structure
reveals that Leu141 and Asp148 play a central role in
the recognition of caspase-7, serving as the anchoring
residues for the hydrophobic and hydrophilic contact
regions, respectively. On the other hand, Val147 and
Figure 2. Superposition of Caspase-7 and Caspase-3
Ile149 are both involved in van der Waals interactions
The backbones of caspase-7 and caspase-3 (PDB code 1CP3) are with neighboring caspase-7 residues (Figures 3 and 4).
colored cyan and pink, respectively. The XIAP inhibitor bound to
Thus, the structure is in complete agreement with thecaspase-7 is highlighted in red; the tetrapeptide aldehyde bound
results of mutagenesis. Aside from Leu141 and Asp148,to caspase-3 is shown in yellow. The catalytic residues, Cys186 in
caspase-7 and Cys163 in caspase-3, are colored in green. The P1 Val146 also appears to be essential for XIAP interaction
residue (Asp, yellow) in the tetrapeptide inhibitor and the XIAP resi- with caspase-7 as it closely stacks against Leu141 of
due Asp148 (red) are also shown. Asp148 occupies the correspond- XIAP and several residues on caspase-7 (Figure 3C).
ing P4 position in the tetrapeptide. Thus we predict that mutation of this residue will inacti-
vate XIAP inhibition of caspase-7.
Previous studies have identified the catalytic residues
XIAP fragment completely fills this pocket, thus blocking in caspase-7 as well as residues important for substrate
substrate entry (Figure 3A). Several key residues on XIAP binding. The substrates of caspase-7 and -3 share the
such as Leu141 and Asp148, which have been shown recognition sequence Asp-Glu-Xaa-Asp, designated as
to be indispensable for caspase-3 inhibition (Sun et al., P4-P3-P2-P1 residues (Thornberry et al., 1997). The cor-
1999), point into the pocket and make intricate interac- responding binding sites on caspases for these four
tions with surrounding XIAP residues (Figure 3B). Rec- residues are named S4-S3-S2-S1, respectively. The P1
ognition of this caspase-7 pocket by XIAP is dominated (Asp) residue, after which the cleavage occurs, is proxi-
by two regions of contacts, both involving hydrogen mal to the catalytic Cys residue in caspases. Our struc-
bonds and van der Waals interactions. tural analysis reveals that the binding of the XIAP frag-
One of the two binding regions involves predominantly ment to caspase-7 results in the complete occupation of
hydrophobic interactions, with the short a helix and the the catalytic groove, thus preventing entry of substrate
N-terminal half of the extended segment from XIAP (Figure 2).
packing against three loops (L2, L3, and L4) on Although XIAP does not contain any sequence motif
caspase-7 (Figures 3C and 4). At the center, Leu141 and characteristic of the caspase-7 substrates, the atomic
Val146 of XIAP pack closely against each other and interactions between the bound XIAP fragment and cas-
fit snugly into the hydrophobic pocket formed by five pase-7 closely resemble that between the caspase in-
surrounding caspase-7 residues, Thr189, Leu191, Tyr230, hibitor Asp-Glu-Val-Asp-CHO and caspase-7 (Wei et al.,
Trp232, and Phe282. On the periphery, Ala137 on the 2000) (Figure 5). Gly144 of XIAP makes direct van der
short a helix of XIAP interacts with Phe282 and His281 Waals contacts to the two catalytic dyad residues,
while Val147 on the extended segment of XIAP stacks Cys186 and His144, thus occupying the P1 position (Fig-
against Pro235, Ser234, and the aliphatic portion of the ure 5). The P2 position is occupied by Val146 of XIAP,
Arg233 side chain. Reinforcing these interactions, the which makes the same van der Waals interactions with
backbone groups of XIAP make three hydrogen bonds surrounding caspase-7 residues that the P2 residue (Val)
to the side chain (Arg233 and Tyr230) and main chain does in caspase inhibitors (Wei et al., 2000). Val147 and
Asp148 of XIAP occupy the P3 and P4 positions, making(Gly85) atoms on caspase-7. In addition, the Ca atom
Structure of Caspase-7 Bound to XIAP
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Figure 3. Specific Recognition of Caspase-7 by XIAP
(A) Overall view of the catalytic groove on caspase-7, represented by its surface in cyan, and the bound XIAP fragment in pink. The important
residues in XIAP are highlighted in yellow (Leu141, Val146, Val147, Asp148, and Ile149). The same XIAP/caspase-7 orientation is maintained
for panels (B) and (C). This panel was prepared using GRASP (Nicholls et al., 1991). (B) Overall view of the interface highlighting the four loops
that constitute the catalytic groove. Caspase-7 and XIAP are shown in green and pink, respectively. The side chains of the critical contact
residues in XIAP are labeled and shown in orange. The coloring scheme is the same for panels (C) and (D). (C) Stereo view of the hydrophobic
interface involving a short a helix and the N-terminal half of the extended segment from XIAP. To avoid congestion, only those critical contact
residues that are not labeled in panel (B) are labeled here. (D) Stereo view of the hydrophilic interface involving the C-terminal half of the
extended XIAP segment. Hydrogen bonds are represented by red dashed lines.
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Figure 4. Sequence Alignment of IAPs (A)
and Caspases (B)
The catalytic dyad residues are shown in red
whereas the conserved amino acids are high-
lighted in yellow. Red and yellow arrows iden-
tify those residues that make intermolecular
hydrogen bonds using their side chain and
main chain atoms, respectively. The residues
that contribute to intermolecular van der
Waals contacts are marked with brown
squares. The residues whose mutation abol-
ished or decreased caspase-3 inhibition (Sun
et al., 1999) are shown as red and green cir-
cles, respectively. The secondary structural
elements as well as the four loops in XIAP-
BIR3 are indicated above the sequence
alignment.
van der Waals contacts and hydrogen bonds to the cient for binding and inhibiting caspase-3 or -7. The
BIR2 domain is completely disordered in the crystals,surrounding caspase-7 residues, respectively. Both
Asp148 of XIAP and the P4 residue in the tetrapeptide suggesting that the interaction, if any, between BIR2
and caspase-7 must be weak. Indeed, we can not detectinhibitor make hydrogen bonds to Gln276 in caspase-7
(Figure 5). stable complex formation using a variety of biochemical
techniques including gel filtration, GST-mediated pull-Thus, four residues on XIAP, Gly144-Val146-Val147-
Asp148, interact with the S1-S2-S3-S4 sites on caspase-7 down assays, and native gel electrophoresis (data not
shown). This apparent discrepancy led us to hypothe-by occupying the P1-P2-P3-P4 positions, respectively.
The P1 position is occupied by the amino-terminal size that the linker peptide by itself adopts an “unpro-
ductive” conformation incapable of forming an inhibitoryGly144 of these four residues. This orientation is the
reverse of that observed for the tetrapeptide caspase complex with caspase-3 or -7. In this case, the BIR
domain might simply be required to avoid the unproduc-inhibitor, in which the P1 position is occupied by the
carboxy-terminal Asp (Wei et al., 2000). Strikingly, de- tive conformation for the peptide, and not for direct
binding and inhibition of caspase-3 or -7. Because thespite this reversal in orientation, a significant subset of
the interactions is conserved between these complexes BIR domain can be attached either N- or C-terminal to
the linker peptide, we reasoned that this unproductive(Figure 5).
conformation could be avoided by tethering at least one
terminus of the linker peptide to a folded domain. ThisDispensable Role of BIR2 in Caspase-7 Binding
and Inhibition hypothesis, if verified true, would explain both the exper-
imental data and the role of the BIR domains.Although residues in the linker region between the BIR1
and BIR2 domains of XIAP play a central role in the If our hypothesis is correct, then other proteins, when
fused to either terminus of the linker peptide, shouldinhibition of caspase-3, the linker region by itself was
found to be insufficient for inhibiting caspase-3, sug- also be able to prevent the unproductive conformation,
allowing the linker peptide to bind and to inhibit cas-gesting that the linker peptide alone is unable to bind
caspase-3 (Sun et al., 1999). This result led to the conclu- pase-3 and -7. To test this conjecture, we created a
fusion protein between glutathione-S transferase (GST)sion that the BIR domain may be indispensable for cas-
pase inhibition (Sun et al., 1999). However, given the and the linker peptide (residues 124–157) and examined
possible interactions with active caspase-3 or -7 usingfact that neither BIR1 nor BIR2 domain by itself binds
or inhibits caspase-3 (Sun et al., 1999), this observation glutathione resin-mediated pulldown assays. The re-
sults demonstrate that, indeed, both caspase-3 and cas-appears quite perplexing. More surprisingly, an engi-
neered protein with the linker peptide fused either N- pase-7 interact strongly with the GST-linker peptide fu-
sion (Figure 6A, lane 2). As a negative control, a fusionor C-terminal to the BIR1 domain was fully able to bind
and inhibit caspase-3 (Sun et al., 1999). protein between GST and BIR2 (residues 156–240) was
unable to interact with either caspase-3 or caspase-7Our crystal structure, on the other hand, clearly dem-
onstrates that the linker peptide by itself should be suffi- (Figure 6, lane 3). To assess the strength of interactions,
Structure of Caspase-7 Bound to XIAP
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subjected to gel filtration analysis (Figure 7B, lower
panel). Indeed, Smac protein dissociates the XIAP frag-
ment from the caspase-7/XIAP complex and forms a
distinct complex with this XIAP fragment (Figure 7B).
This result suggests competitive binding to XIAP by
Smac and by caspase-7. Interestingly, Smac does not
interact directly with the linker peptide (residues 124–
157, data not shown); rather, Smac binds tightly to the
BIR2 domain of XIAP (157–240), using both its N-terminal
tetrapeptide and a protein–protein interface (Chai et al.,
2000; Liu et al., 2000; Srinivasula et al., 2000; Wu et al.,
2000). These observations suggest that the removal of
XIAP inhibition to caspase-7 may not involve direct com-
petition for binding to the same XIAP surface by Smac
and by caspase-7. Alternatively, this may require confor-
mational change or steric hindrance. Indeed, previous
study suggests that the XIAP-BIR2 domain may dimerize
upon binding to Smac (Chai et al., 2000), which results
in the burial of the N termini of these BIR2 domains
(Figure 7C). The buried residues would likely include
Asp148 and Val146, which also play a key role in binding
and inhibiting caspase-7. Based on this analysis, we
postulate that Smac binding to the BIR2 domain may
restrict the topology of the linker peptide such that the
peptide can no longer bind and inhibit caspase-7 (Figure
7C). Although this model is consistent with our biochem-
ical and structural evidence, more detailed studies are
needed.
Discussion
It was recently realized that different BIR domains in theFigure 5. Comparison of Caspase-7 Binding by XIAP (A) and a Tet-
same IAP protein exhibit distinct functions. For example,rapeptide Aldehyde Inhibitor (Wei et al., 2000) (B)
although the three BIR domains of XIAP share significantThe XIAP fragment and the tetrapeptide inhibitor are shown in thick
homology, only the BIR3 domain can potently inhibitlines whereas the surrounding caspase-7 residues are represented
active caspase-9 (Sun et al., 2000). On the other hand,in thin lines. All important residues are labeled.
BIR3 does not show any inhibitory effect toward cas-
pase-3 and -7. A recent report identified the linker region
between the BIR1 and BIR2 domains of XIAP to bewe quantified the binding affinity using isothermal titra-
tion calorimetry (Figure 6B). The best fit of the binding critically important for caspase-3 inhibition. However,
the removal of the BIR domain led to complete loss ofdata gives rise to a dissociation constant of 0.63 6 0.04
mM for a complex between caspase-7 and GST-linker inhibition by the linker peptide, prompting a conclusion
that the BIR domains may be important for the inhibitionpeptide (Figure 6B). In contrast, neither GST nor the
linker peptide alone binds caspase-7 detectably (data of caspsae-3 or -7 (Sun et al., 1999). In this study, we
demonstrate that the BIR domains are dispensable fornot shown).
Next, we examined whether the GST-linker peptide the inhibition of caspase-3 and -7. A fusion protein be-
tween GST and the linker peptide of XIAP tightly bindscould inhibit the enzymatic activity of caspase-7. Using
the fluorogenic peptide Asp-Glu-Val-Asp-AFC as the to and potently inhibits caspase-7 and -3. These results
strongly indicate that one of the primary roles of thesubstrate, GST-linker peptide potently inhibits caspase-7
activity, with an IC50 value of z100 nM (Figure 6C). This flanking BIR domains is to relieve the linker peptide from
an unproductive conformation that precludes bindingresult is in good agreement with the IC50 value of 67
nM for the XIAP-BIR1-linker peptide fragment. In sharp to and inhibition of caspase-3 and -7. Although the BIR2
domain is disordered in the crystals, it is important tocontrast, neither GST nor the peptide by itself (residues
124–157) exhibited any detectable inhibition toward cas- realize that this domain is not unstructured or unfolded.
We simply do not “see” this domain because it wobblespase-7 at 1 mM concentration (data not shown).
in the solvent cavity in the crystals.
These results are in excellent agreement with reportedRelief of XIAP Inhibition to Caspase-7 by Smac
The inhibition of caspase-7 by XIAP can be removed by experimental observations. In particular, our study ex-
plains (1) why the BIR domain can be attached to eitherSmac (Figure 7A). One way to achieve this is through
mutual exclusion of caspase-7 and Smac for binding to the N or the C terminus of the linker peptide with similar
inhibitory effect (Sun et al., 1999), and (2) why the BIRXIAP. To examine this scenario, a complex between
active caspsae-7 and XIAP (residues 124–240) was incu- domain can be either BIR1 or BIR2 (Sun et al., 1999). In
fact, the BIR domain can be replaced by GST; the re-bated with the mature form of Smac protein and then
Cell
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Figure 6. The BIR Domains Are Dispensable
for Caspase Inhibition
(A) Interaction of caspase-3 and -7 with vari-
ous XIAP fragments. All XIAP fragments were
created and purified as GST-fusion proteins.
Glutathione resin-mediated GST-pulldown
assay was used to examine interactions with
active caspase-3 or -7. A representative SDS-
PAGE gel is shown on the left for caspase-3.
The results are tabulated on the right. (B) Iso-
thermal titration calorimetry for the interac-
tion between caspase-7 and GST-linker pep-
tide (124–157). The top part shows the actual
titration data whereas the bottom part shows
the curve fitting and the dissociation con-
stant. (C) Inhibition of caspase-7 activity by
the GST-linker peptide (124–157). The IC50
value is comparable to that reported for the
BIR1-linker peptide fragment (Sun et al.,
1999).
sulting fragment still retains similar levels of inhibition the BIR domains by GST resulted in similar levels of
inhibition. Nevertheless, we can not rule out a minor roleto the enzymatic activities of caspase-3 and -7. Although
restraining one terminus of the linker peptide allows for the BIR domains in caspase inhibition. Although the
BIR2 domain is dispensable for caspase-7 inhibition, itinhibition of caspase-7, it is possible that tethering both
termini exhibits a stronger effect. Indeed, GST-linker- may have other important biological functions besides
restraining the conformation of the linker peptide. ForBIR2 (residues 124–240) appears to exhibit more potent
inhibition to caspase-7 than either GST-linker or linker- example, the BIR2 domain may be necessary for the
relief of XIAP inhibition to caspase-7 or caspase-3 be-BIR2 alone (data not shown).
Interestingly, a number of residues on the XIAP-BIR2 cause Smac binds this domain but does not interact
directly with the XIAP linker peptide.domain exhibited chemical shift changes upon binding
to caspase-3, suggesting involvement in interactions What unproductive conformations could the linker
peptide adopt? There are at least two possibilities. One(Sun et al., 1999). However, a closer examination of these
residues suggests that the interactions involved may not involves tight intramolecular interactions, perhaps re-
quiring both termini to be free. The linker peptide withbe biologically significant. First, most of these residues,
such as Tyr154, Asn157, Tyr161, Gln197, Gln199, and this conformation, dubbed “knot,” may exist as a mono-
mer. The other possibility is that the linker peptidesLys208, are not conserved among any two BIR domains
in XIAP or cIAP-1. This aspect is not in agreement with aggregate to form higher-order complexes. In both sce-
narios, the tethering of BIR domains or GST preventthe fact that both cIAP-1 and XIAP can potently inhibit
caspase-3. Second, mutation of these residues does the unproductive conformations. More detailed study is
needed to differentiate between these two possibilities.not affect the inhibition of XIAP to caspase-3 (Sun et
al., 1999). Third, and most importantly, replacement of Our structural analysis shows that the XIAP linker pep-
Structure of Caspase-7 Bound to XIAP
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Figure 7. A Proposed Mechanism for the Re-
moval of XIAP Inhibition to Caspase-7 by
Smac/DIABLO
(A) Smac/DIABLO is able to remove the XIAP
inhibition to the enzymatic activity of cas-
pase-7 as shown by a time course analysis.
The XIAP fragment (residues 124–240) con-
tains both the linker peptide and the BIR2
domain. (B) Smac/DIABLO and caspase-7
compete to form a mutually exclusive com-
plex with an XIAP fragment (124–240) as
judged by gel filtration. The caspase-7/XIAP
complex by itself is eluted in fractions 27–29
(upper panel) while Smac selectively forms a
complex with the XIAP fragment and pulls
it into fractions 23–25 (bottom panel). (C) A
proposed model for the mutual exclusion be-
tween Smac and caspase-7 for binding to
XIAP. The arch-shaped Smac dimer is repre-
sented in red and brown. The two XIAP-BIR2
domains, colored blue and pink, respectively,
are modeled to interact with Smac based on
previous work (Wu et al., 2000). This binding
mode would leave the amino-termini (residue
151) of both BIR2 domains underneath the
Smac dimer and unavailable for interaction
with caspase-7 because the carboxy-termini
(residue 151) of the XIAP linker peptides are
bound to caspase-7 in the crystal structure.
tide wraps around the active site of caspase-7, thus tacts to XIAP, only 7 are conserved in caspase-9 (Figure
4). In addition, the critical L4 loop is significantly short-precluding substrate entry and binding. Interestingly, the
orientation of the XIAP peptide with respect to caspase- ened in caspase-9 (Figure 4), likely affecting the overall
shape of the catalytic cleft.7 is reversed relative to the orientation of the inhibitory
tetrapeptide aldehyde Asp-Glu-Val-Asp-CHO. Nonethe- Two other IAPs, cIAP-1 and cIAP-2, are also known
to inhibit caspase-3 and -7. Sequence alignment amongless, many of the detailed atomic interactions are con-
served. It is striking that nature has chosen an opposite IAPs suggests that the mode of binding or inhibition
should be conserved. For example, the two anchoringorientation of caspase inhibitor. Thus, this finding opens
new avenues for the design of caspase inhibitors. residues in XIAP, Leu141 and Asp148, are invariant in
both cIAP-1 and cIAP-2. However, comparing to XIAP,Caspase-3 shares 54% sequence identity with cas-
pase-7. Consequently, the backbone structures of cas- the inhibitory constants for cIAP-1 and c-IAP2 are about
100-fold weaker (Deveraux and Reed, 1999). Our struc-pase-3 and -7 are nearly identical (Figure 2). In particular,
70% of the caspase-7 residues that interact with XIAP tural analysis provides a reasonable explanation. In
XIAP, four residues, Gly144-Val146-Val147-Asp148, playare preserved in caspase-3 (Figure 4). Thus, it is very
likely that XIAP binds caspase-3 in the same manner as a central role by occupying the S1-S2-S3-S4 sites on
caspase-7. Gly144 makes van der Waals contacts toit binds caspase-7. In support of this prediction, the
GST-linker peptide interacts strongly with caspase-3 the catalytic dyad residues Cys186 and His144. In
cIAP-1 and cIAP-2, however, at least two of these four(Figure 6).
Sequence alignment among caspase-3, -7, and -9 critical residues have been replaced. These four resi-
dues are Arg164-Val166-Glu167-Asp168 and Arg149-also reveals the structural basis for the observation that
the XIAP linker peptide does not interact with caspase-9. Asn151-Gln152-Asp153 for cIAP-1 and cIAP-2, respec-
tively. These residues are unlikely to maintain the sameFor the 17 caspase-7 residues that mediate direct con-
Cell
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Structure Determinationextensive contacts as observed between XIAP and
The structure was determined by molecular replacement, using thecaspase-7. In particular, replacement of Gly by a bulky
software AMORE (Navaza, 1994). The atomic coordinates of cas-Arg at the P1 position is expected to disrupt local
pase-3 (PDB code 1CP3) were used for rotational research against
packing. a 15–3.5 A˚ data set. The top 50 solutions from the rotational search
On the basis of biochemical evidence, we also sug- were individually used for a subsequent translational search, which
yielded two promising solutions with correlation factors of 20.8–22.0gest a model for the relief of XIAP inhibition to caspase-7
and R factors of 52.4%–53.0%. These two solutions turn out to beby Smac/DIABLO (Figure 7). The relief of XIAP inhibition
the two complexes in one asymmetric unit in the crystals; together,to caspase-7 relies on the full-length Smac protein (Fig-
they give a combined correlation factor of 33.5 and an R factor ofure 7); and the N-terminal tetrapeptide of Smac is clearly
44%. This model was examined with the program O (Jones et al.,
insufficient for this function as it only binds a surface 1991), and the caspase-3 side chains were replaced with those of
groove on the disordered BIR2 domain (Chai et al., 2000; caspase-7 all at once. Refinement by the program CNS (Brunger et
al., 1998), against the 2.7 A˚ native data set, quickly decreased theLiu et al., 2000). Preliminary experiments suggest that
R factor and Rfree to 28% and 31%, respectively. The electron densitythe mechanisms for the relief of XIAP inhibition to cas-
for the XIAP fragment was very clear at the active site of caspase-7.pase-3 are likely to be more complex (data not shown).
A model was built with the program O and refined further by simu-Although the detailed mechanisms remain unclear for
lated annealing using the program CNS. The final refined atomic
caspase-3, the bound XIAP fragment must be removed, model contains caspase-7 residues 58–303, XIAP residues 133–151,
perhaps transiently, in order to allow substrate entry and 111 ordered water molecules at 2.45 A˚ resolution. The N-termi-
nal 7 residues and the His6 tag in caspase-7 and the completeand any enzymatic activity.
BIR2 domain in XIAP have no electron density in the maps, and weIn summary, we have determined the crystal structure
presume that these regions are disordered in the crystals.between a caspase, caspase-7, and a naturally oc-
curring caspase inhibitor, XIAP. In conjunction with our
biochemical studies, a novel mechanism of inhibition is In Vitro Interaction Assay
revealed, where the BIR domains are not directly in- Interaction between caspase-3 or -7 and XIAP was examined by
GST-mediated pulldown assays. Approximately 0.4 mg of a recom-volved in binding or inhibiting caspase-7 but serve to
binant XIAP fragment was bound to 200 ml of glutathione resin aspresent a productive conformation for the linker peptide.
a GST-fusion protein and incubated with wild-type caspase-3 or -7In addition to reconciling a body of experimental obser-
at room temperature. After extensive washing with an assay buffer
vations, our studies provide a framework for the design containing 25 mM Tris, pH 8.0, 150 mM NaCl, and 2 mM dithiothreitol
of the next-generation caspase inhibitors. (DTT), the complex was eluted with 5 mM reduced glutathione and
visualized by SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
with Coomassie staining.Experimental Procedures
Protein Preparation
Assay for Caspase-7 Activity and InhibitionAll constructs were generated using a standard PCR-based cloning
Caspase-7 enzymatic assays were performed in a 20 ml reactionstrategy, and the identities of individual clones were verified through
volume of buffer A (20 mM HEPES, pH 7.5, 10 mM KCl, 1.5 mMdouble-stranded plasmid sequencing. Because the N-terminal 50
MgCl2, 1 mM EDTA, 1mM EGTA, 1 mM dithiothreitol) at 378C. Inresidues are unimportant for caspase-7 activity and disordered in
Figure 6C, various concentrations of pure GST-XIAP linker peptidea reported crystal structure, they are removed in the caspase-7
(124–157) were incubated with caspase-7 (1 nM) and 100 mM fluoro-construct (residues 51–303). Caspase-7 and -3 were overexpressed
genic peptide substrate DEVD-AFC for 30 min. The release of AFCin Escherichia coli strain BL21(DE3) as C-terminally 6-Histidine-
from the substrate was monitored using a PerkinElmer Life Sciencestagged proteins using a pET-21b vector (Novagen). The soluble
luminescence spectrometer. In Figure 7A, effects of Smac/DIABLOfraction of the recombinant protein in the E. coli lysate was purified
on XIAP inhibition of caspase-7 activity were determined by incubat-over a Ni-NTA (Qiagen) column, and further fractionated by anion
ing caspase-7 (1 nM) with 10 nM GST-XIAP (residues 124–240) andexchange (Source-15Q, Pharmacia) and gel-filtration chromatogra-
500 nM of pure recombinant Smac in the presence of 100 mM fluoro-phy (Superdex-200, Pharmacia). Recombinant XIAP fragments were
genic peptide substrate DEVD-AFC. At different time intervals theoverexpressed as GST-fusion proteins using pGEX-2T (Pharmacia).
release of AFC from the substrate was monitored using a Perkin-The soluble fraction of the GST-IAP fusion in the E. coli lysate was
Elmer Life Sciences luminescence spectrometer. The results werepurified over a glutathione sepharose column, and further purified
expressed as relative fluorogenic units of DEVD cleavage and shownby anion-exchange chromatography (Source-15Q, Pharmacia). The
as the average of three independent experiments.purified GST-XIAP protein was immobilized onto glutathione resin
and the purified caspase-7 was allowed to flow through the resin.
The binary complex was eluted by reduced glutathione, cleaved by
Isothermal Microcalorimetry Titrationthrombin, and further purified through a gel filtration column.
All proteins and peptides were prepared in 50 mM sodium phos-
phate buffer, pH 7.5. The Micro Calorimetry System (Microcal, Am-
Crystallization and Data Collection herst, MA) was used to perform the ITC measurements for the inter-
Crystals were grown by the hanging-drop vapor-diffusion method action between the linker peptide or GST-linker peptide and
by mixing the caspase-7/XIAP complex (5 mg/ml) with an equal caspase-7. The titration data, collected at 238C, were analyzed using
volume of reservoir solution containing 25 mM Tris, pH 8.0, 0.5 M the ORIGIN data analysis software (Microcal Software, Northamp-
ammonium sulfate, 15% PEG 4000, and 10 mM DTT. Multiple crys- ton, MA).
tals appeared overnight. Macroseeding yielded crystals with a maxi-
mum size of 0.2 3 0.2 3 0.4 mm3 over a period of 6–7 days. The
crystals are in the primitive trigonal space group P3221, with unit Acknowledgments
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